v3.26.1
Summary of Significant Accounting Policies (Liquidity) - (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Aug. 04, 2026
Jun. 27, 2026
Mar. 28, 2026
Jun. 28, 2025
Mar. 29, 2025
Jun. 27, 2026
Jun. 28, 2025
Dec. 27, 2025
Dec. 28, 2024
Concentration Risk [Line Items]                  
Net Income (Loss)   $ 1,403 $ 8,645 $ (6,078) $ (9,487) $ 10,048 $ (15,565)    
Working capital deficit           22,100      
Total assets   73,313       73,313   $ 49,477  
Cash, cash equivalents and restricted cash at end of period   40,655   29,038   40,655 29,038    
Total stockholders' equity (deficit)   $ 23,183 $ 10,444 $ (6,958) $ (13,672) $ 23,183 $ (6,958) $ (5,203) $ (6,048)
Subsequent event | Patent Cross License Agreement                  
Concentration Risk [Line Items]                  
Upfront license fee, net of withholding tax $ 200,000